SPDR S&P Biotech ETF (XBI) -1.7%
For a second day, biotechnology stocks are heading lower, pushing ETFs like XBI and the iShares NASDAQ Biotechnology Index Fund (IBB) to the top of the loser's list. At the start of the week, I warned investors that these funds could be set to take a breather given their impressive run ups during the opening weeks of the year. Continue to keep them on the radar.
All prices as of 2:12 PM EST.
Written by Don Dion in Williamstown, Mass.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts